GAA genepharm australasia limited

Forecast $5.75M NPAT for 2008.May have 125M shares on issue...

  1. Vayama
    9,286 Posts.
    clock Created with Sketch.
    27/11/07
    20:58
    Post #: 3052040
    Forecast $5.75M NPAT for 2008.

    May have 125M shares on issue after buy back.

    This equals 4.6 cents EPS for 2008.

    Place on a PE ratio of 14 and the share price target is 65 cents.
    GAA Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add GAA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.